Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGG492 adjunctive therapy in partial-onset seizures
2009-017961-52Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of selurampanel in focal-onset epileptic seizures and Focal Onset Epilepsy (3 arms), sponsored by Novartis. Started Mar 2010; status: completed.
02
Drugs
selurampanel
03
Conditions
focal-onset epileptic seizuresFocal Onset Epilepsy
Beyond the preview
Go deeper on 2009-017961-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017961-52.